Increasing the concentration of IL-21 in the TME could reverse the failure of NK cells by activating the phosphoinositide 3-kinase (PI3K)-AKT-FoxO1 and signal transducer and activator of transcription 1 (STAT1) signalling pathways to improve the prognosis of advanced tumours (98). The gene discussed is STAT1; the disease is neoplasm.